AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
HEREDITARY INSENSITIVITY TO PAIN WITH ANHIDROSIS
Authors: BERKOVITCH M COPELIOVITCH L TAUBER T VAKNIN Z LAHAT E
Citation: M. Berkovitch et al., HEREDITARY INSENSITIVITY TO PAIN WITH ANHIDROSIS, Pediatric neurology, 19(3), 1998, pp. 227-229
TRYING TO IMPROVE COMPLIANCE WITH PROPHYLACTIC PENICILLIN THERAPY IN CHILDREN WITH SICKLE-CELL DISEASE
Authors: BERKOVITCH M PAPADOURIS D SHAW D ONUAHA N DIAS C OLIVIERI NF
Citation: M. Berkovitch et al., TRYING TO IMPROVE COMPLIANCE WITH PROPHYLACTIC PENICILLIN THERAPY IN CHILDREN WITH SICKLE-CELL DISEASE, British journal of clinical pharmacology, 45(6), 1998, pp. 605-607
CLINICAL RELEVANCE OF THERAPEUTIC DRUG-MONITORING OF DIGOXIN AND GENTAMICIN IN THE SALIVA OF CHILDREN
Authors: BERKOVITCH M BISTRITZER T ALADJEM M BURTIN P DAGAN T CHENLEVI Z FREEDOM R KOREN E
Citation: M. Berkovitch et al., CLINICAL RELEVANCE OF THERAPEUTIC DRUG-MONITORING OF DIGOXIN AND GENTAMICIN IN THE SALIVA OF CHILDREN, Therapeutic drug monitoring, 20(3), 1998, pp. 253-256
INTRANASAL MIDAZOLAM FOR CHILDHOOD SEIZURES
Authors: LAHAT E GOLDMAN M BARR J ESHEL G BERKOVITCH M
Citation: E. Lahat et al., INTRANASAL MIDAZOLAM FOR CHILDHOOD SEIZURES, Lancet, 352(9128), 1998, pp. 620-620
STEADY-STATE PHARMACOKINETICS OF ISOTRETINOIN AND ITS 4-OXO METABOLITE - IMPLICATIONS FOR FETAL SAFETY
Authors: NULMAN I BERKOVITCH M KLEIN J PASTUSZAK A LESTER RS SHEAR N KOREN G
Citation: I. Nulman et al., STEADY-STATE PHARMACOKINETICS OF ISOTRETINOIN AND ITS 4-OXO METABOLITE - IMPLICATIONS FOR FETAL SAFETY, Journal of clinical pharmacology, 38(10), 1998, pp. 926-930
HELIOX THERAPY FOR PNEUMOTHORAX - NEW INDICATION FOR AN OLD REMEDY
Authors: BARR J LUSHKOV G STARINSKY R KLIN B BERKOVITCH M ESHEL G
Citation: J. Barr et al., HELIOX THERAPY FOR PNEUMOTHORAX - NEW INDICATION FOR AN OLD REMEDY, Annals of emergency medicine, 30(2), 1997, pp. 159-162
SALIVARY MEASUREMENT OF DEFERIPRONE CONCENTRATIONS AND CORRELATION WITH SERUM LEVELS
Authors: POPE E BERKOVITCH M KLEIN J FASSOS F KOREN G
Citation: E. Pope et al., SALIVARY MEASUREMENT OF DEFERIPRONE CONCENTRATIONS AND CORRELATION WITH SERUM LEVELS, Therapeutic drug monitoring, 19(1), 1997, pp. 95-97
ACUTE IRON INTOXICATION - SIGNIFICANT DIFFERENCES BETWEEN SEXES
Authors: BERKOVITCH M LIVNE A LUSHKOV G BARR J TAUBER T ESHEL G KOREN G BISTRITZER T
Citation: M. Berkovitch et al., ACUTE IRON INTOXICATION - SIGNIFICANT DIFFERENCES BETWEEN SEXES, Veterinary and human toxicology, 39(5), 1997, pp. 265-267
IMMUNE FUNCTION IN PATIENTS WITH BETA-THALASSEMIA RECEIVING THE ORALLY-ACTIVE IRON-CHELATING AGENT DEFERIPRONE
Authors: LOEBSTEIN R DALAL I NISBETBROWN E BERKOVITCH M MEYDAN N ANDREWS D LOUBSER MD KOREN G ROIFMAN CM OLIVIERI NF
Citation: R. Loebstein et al., IMMUNE FUNCTION IN PATIENTS WITH BETA-THALASSEMIA RECEIVING THE ORALLY-ACTIVE IRON-CHELATING AGENT DEFERIPRONE, British Journal of Haematology, 98(3), 1997, pp. 597-600
PHARMACOKINETICS OF ARGININE BUTYRATE IN PATIENTS WITH HEMOGLOBINOPATHY
Authors: BERKOVITCH M SHER G MCCLELAND R MATSUI D HADZIALIC G OLIVIERI NF KOREN G
Citation: M. Berkovitch et al., PHARMACOKINETICS OF ARGININE BUTYRATE IN PATIENTS WITH HEMOGLOBINOPATHY, Environmental toxicology and pharmacology, 2(4), 1996, pp. 403-405
HEPATOTOXICITY OF 6-MERCAPTOPURINE IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - PHARMACOKINETIC CHARACTERISTICS
Authors: BERKOVITCH M MATSUI D ZIPURSKY A BLANCHETTE VS VERJEE Z GIESBRECHT E SAUNDERS EF EVANS WE KOREN G
Citation: M. Berkovitch et al., HEPATOTOXICITY OF 6-MERCAPTOPURINE IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - PHARMACOKINETIC CHARACTERISTICS, Medical and pediatric oncology, 26(2), 1996, pp. 85-89
EFFICACY OF PRILOCAINE-LIDOCAINE CREAM IN THE TREATMENT OF PREMATURE EJACULATION
Authors: BERKOVITCH M KERESTECI AG KOREN G SAHIN H BIRCAN MK
Citation: M. Berkovitch et al., EFFICACY OF PRILOCAINE-LIDOCAINE CREAM IN THE TREATMENT OF PREMATURE EJACULATION, The Journal of urology, 156(5), 1996, pp. 1783-1784
PHARMACOKINETICS (PK) OF ISOTRETINOIN (IT) AND ITS 4-OXO METABOLITE AT STEADY-STATE
Authors: NULMAN I KLEIN J BERKOVITCH M LESTER RS SHEAR N KOREN G
Citation: I. Nulman et al., PHARMACOKINETICS (PK) OF ISOTRETINOIN (IT) AND ITS 4-OXO METABOLITE AT STEADY-STATE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 51-51
THE DENSE CORE, OUTFLOW, AND JET IN L810 - HIGH-RESOLUTION HAYSTACK OBSERVATIONS AT 3 MILLIMETERS
Authors: CLEMENS DP BERKOVITCH M YUN JL PATEL N XIE TL
Citation: Dp. Clemens et al., THE DENSE CORE, OUTFLOW, AND JET IN L810 - HIGH-RESOLUTION HAYSTACK OBSERVATIONS AT 3 MILLIMETERS, The Astrophysical journal, 457(2), 1996, pp. 743-751
ASSESSMENT OF THE TERMINAL 40-MILLISECOND QRS VECTOR IN CHILDREN WITHA HISTORY OF TRICYCLIC ANTIDEPRESSANT INGESTION
Authors: BERKOVITCH M MATSUI D FOGELMAN R KOMAR L HAMILTON R JOHNSON D
Citation: M. Berkovitch et al., ASSESSMENT OF THE TERMINAL 40-MILLISECOND QRS VECTOR IN CHILDREN WITHA HISTORY OF TRICYCLIC ANTIDEPRESSANT INGESTION, Pediatric emergency care, 11(2), 1995, pp. 75-77
EVALUATION OF THERAPEUTIC DRUG-MONITORING OF METHOTREXATE IN SALIVA OF CHILDREN WITH RHEUMATIC DISEASES (VOL 17, PG 247, 1995)
Authors: PRESS J BERKOVITCH M LAXER R GIESBRECHT E VERJEE Z SILVERMAN E KLEIN J KOREN G
Citation: J. Press et al., EVALUATION OF THERAPEUTIC DRUG-MONITORING OF METHOTREXATE IN SALIVA OF CHILDREN WITH RHEUMATIC DISEASES (VOL 17, PG 247, 1995), Therapeutic drug monitoring, 17(4), 1995, pp. 436-436
EVALUATION OF THERAPEUTIC DRUG-MONITORING OF METHOTREXATE IN SALIVA OF CHILDREN WITH RHEUMATIC DISEASES
Authors: PRESS J BERKOVITCH M LAXER R GIESBRECHT E SILVERMAN E KLEIN J KOREN G
Citation: J. Press et al., EVALUATION OF THERAPEUTIC DRUG-MONITORING OF METHOTREXATE IN SALIVA OF CHILDREN WITH RHEUMATIC DISEASES, Therapeutic drug monitoring, 17(3), 1995, pp. 247-250
USE OF A EUTECTIC MIXTURE OF LOCAL-ANESTHETICS FOR PROLONGED SUBCUTANEOUS DRUG ADMINISTRATION
Authors: BERKOVITCH M DAVIS S MATSUI D DONSKY J KOREN G OLIVIERI NF
Citation: M. Berkovitch et al., USE OF A EUTECTIC MIXTURE OF LOCAL-ANESTHETICS FOR PROLONGED SUBCUTANEOUS DRUG ADMINISTRATION, Journal of clinical pharmacology, 35(3), 1995, pp. 295-297
IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR
Authors: OLIVIERI NF BRITTENHAM GM MATSUI D BERKOVITCH M BLENDIS LM CAMERON RG MCCLELLAND RA LIU PP TEMPLETON DM KOREN G
Citation: Nf. Olivieri et al., IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR, The New England journal of medicine, 332(14), 1995, pp. 918-922
EFFICACY OF PRILOCAINE-LIDOCAINE CREAM IN THE TREATMENT OF PREMATURE EJACULATION
Authors: BERKOVITCH M KERESTECI AG KOREN G
Citation: M. Berkovitch et al., EFFICACY OF PRILOCAINE-LIDOCAINE CREAM IN THE TREATMENT OF PREMATURE EJACULATION, The Journal of urology, 154(4), 1995, pp. 1360-1361
BAEP STUDIES IN CHILDREN WITH ATTENTION-DEFICIT DISORDER
Authors: LAHAT E AVITAL E BARR J BERKOVITCH M ARLAZOROFF A ALADJEM M
Citation: E. Lahat et al., BAEP STUDIES IN CHILDREN WITH ATTENTION-DEFICIT DISORDER, Developmental Medicine and Child Neurology, 37(2), 1995, pp. 119-123
PEMOLINE-ASSOCIATED FULMINANT LIVER-FAILURE - TESTING THE EVIDENCE FOR CAUSATION
Authors: BERKOVITCH M POPE E PHILLIPS J KOREN G
Citation: M. Berkovitch et al., PEMOLINE-ASSOCIATED FULMINANT LIVER-FAILURE - TESTING THE EVIDENCE FOR CAUSATION, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 696-698
THE FIRST PROSPECTIVE RANDOMIZED TRIAL OF SUBCUTANEOUS DEFEROXAMINE AND THE ORALLY-ACTIVE CHELATING AGENT
Authors: POPE E BERKOVITCH M OLIVIERI NF KOREN G
Citation: E. Pope et al., THE FIRST PROSPECTIVE RANDOMIZED TRIAL OF SUBCUTANEOUS DEFEROXAMINE AND THE ORALLY-ACTIVE CHELATING AGENT, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 208-208
EXPERIENCE WITH MISOPROSTOL THERAPY FOR NSAID GASTROPATHY IN CHILDREN
Authors: GAZARIAN M BERKOVITCH M KOREN G SILVERMAN ED LAXER RM
Citation: M. Gazarian et al., EXPERIENCE WITH MISOPROSTOL THERAPY FOR NSAID GASTROPATHY IN CHILDREN, Annals of the Rheumatic Diseases, 54(4), 1995, pp. 277-280
PEDIATRIC CLINICAL USE OF THE KETOCONAZOLE CYCLOSPORINE INTERACTION
Authors: BERKOVITCH M BITZAN M MATSUI D FINKELSTEIN H BALFE JW KOREN G
Citation: M. Berkovitch et al., PEDIATRIC CLINICAL USE OF THE KETOCONAZOLE CYCLOSPORINE INTERACTION, Pediatric nephrology, 8(4), 1994, pp. 492-493
Risultati: 1-25 | 26-49